0000905148-24-000760.txt : 20240216
0000905148-24-000760.hdr.sgml : 20240216
20240216170648
ACCESSION NUMBER: 0000905148-24-000760
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blume-Jensen Peter
CENTRAL INDEX KEY: 0001950499
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41551
FILM NUMBER: 24649385
MAIL ADDRESS:
STREET 1: C/O ACRIVON THERAPEUTICS, INC.
STREET 2: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781174
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825125532
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-207-8979
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
form4.xml
X0508
4
2024-02-14
0001781174
Acrivon Therapeutics, Inc.
ACRV
0001950499
Blume-Jensen Peter
C/O ACRIVON THERAPEUTICS, INC.
480 ARSENAL WAY, SUITE 100
WATERTOWN
MA
02472
true
true
President and CEO
false
Common Stock
2024-02-14
4
F
0
41861
3.4
D
2616812
D
Common Stock
318226
I
See Footnote
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
These securities are held by co-founder and EVP, Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
2024-02-16